SCHEMBL3441240

SCHEMBL3441240

CCc1nc2ccccc2n(CC2CC2)c1=O.CCn1c(=O)c(C(C)C)nc2ccc(C)cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
BRD4 O60885 4/20 0.43
BAZ2A Q9UIF9 2/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
POLB P06746 1/20 0.42
PTGER4 P35408 5/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRM2 Q14416 1/20 0.39
ACSS2 Q9NR19 1/20 0.39
PDE6D O43924 1/20 0.38
NLRP3 Q96P20 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980644 0.81 KDM4E (0.69) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL983125 0.80 ACSS2 (0.49) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL982527 0.78 MAPK1 (0.66) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL31300308 0.76 KDM4E (0.63) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL981898 0.74 KDM4E (1.00) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL983242 0.71 KDM4E (0.49) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL980698 0.68 PDE4A (0.54) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL31448372 0.68 CFTR (0.52) KDM4EALDH1A1HPGDHSD17B10BRD4
SCHEMBL16872617 0.67 KDM4E (0.73) MAPK1KDM4EALDH1A1LMNAHPGD
SCHEMBL18731913 0.67 CNR2 (0.48) MAPK1KDM4EALDH1A1BRD4BAZ2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247580-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-10 EP disclosed
WO-2009109258-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-11 WO disclosed